Elevated Levels of Very Low-density Lipoprotein Cholesterol Independently Associated with In-stent Restenosis in Diabetic Patients after Drug-eluting Stent Implantation

Documenti analoghi

• The Predictive Value of Monocyte Count to High-Density Lipoprotein Cholesterol Ratio in Restenosis After Drug-Eluting Stent Implantation
  di: Nan, Jing, et al.
  Pubblicazione: (2020)
• Therapeutic Strategy for In-Stent Restenosis Based on the Restenosis Pattern After Drug-Eluting Stent Implantation
  di: Kim, Ki-Hun, et al.
  Pubblicazione: (2009)
• Efficacy and safety of drug-eluting stent implantation for the treatment of in-stent restenosis occurring within bare-metal stent and drug-eluting stent
  di: Ge, Heng, et al.
  Pubblicazione: (2010)
• Multiple Sequential Complications After Sirolimus-Eluting Stent Implantation: Very Late Stent Thrombosis, Stent Fracture, In-Stent Restenosis, and Peri-Stent Aneurysm
  di: Seol, Sang-Hoon, et al.
  Pubblicazione: (2009)
• Predictors of diffuse-type in-stent restenosis following drug-eluting stent implantation
  di: PARK, CHANG-BUM, et al.
  Pubblicazione: (2013)